Zacks Investment Research on MSN

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its third-quarter 2025 results on Nov. 3, after market close. The Zacks Consensus Estimate for the to-be-reported ...
Zacks Investment Research on MSN

Vertex (VERX) Earnings Expected to Grow: Should You Buy?

Vertex (VERX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the ...